Aug 12, 2021 / 08:30PM GMT
Operator
Greetings. Welcome to the Eledon Pharmaceuticals Report Second Quarter 2021 Financial Results Conference Call. (Operator Instructions) Please note that this conference is being recorded. I will now turn the conference over to your host, Paul Little, Chief Financial Officer. You may begin.
Paul Sean Little - Eledon Pharmaceuticals, Inc. - CFO & Principal Accounting Officer
Good afternoon, and thank you for joining Eledon Pharmaceuticals' Second Quarter 2021 Financial Results Conference Call. Joining me today is David-Alexander Gros, Chief Executive Officer; Steven Perrin, President and Chief Scientific Officer; and Jeff Bornstein, Chief Medical Officer. Earlier today, Eledon issued a press release announcing financial results for the second quarter ended June 30, 2021. You may access the release under the Investors tab on our company website, eledon.com.
Before we begin, I would like to remind everyone that statements made today during this call related to Eledon's expected future performance, future business prospects or future events or plans may
Q2 2021 Eledon Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
